Protective effect of sodium ascorbate on efficacy of intramuscular transplantation of autologous muscle derived cells

Muscle and Nerve

Volumn 45, Issue 1, 2012, Pages 32-38

  Bartoszuk Bruzzone, Urszula ^a   Burdziń, Anna ^b   Orzechowski, Arkadiusz ^a,c   Kłos, Zdzisław ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Autologous; Cellular transplantation; Muscle; Muscle derived cells; Sodium ascorbate

Indexed keywords

ASCORBIC ACID; BETA GALACTOSIDASE;

ARTICLE; AUTOTRANSPLANTATION; CELL ISOLATION; CELL THERAPY; CELL VIABILITY; DRUG EFFECT; HUMAN; MUSCLE CELL; MUSCLE DISEASE; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RABBIT;

ANIMALS; ANTIOXIDANTS; ASCORBIC ACID; BETA-GALACTOSIDASE; CELL SURVIVAL; CELL TRANSPLANTATION; CELLS, CULTURED; DESMIN; DISEASE MODELS, ANIMAL; GREEN FLUORESCENT PROTEINS; INJECTIONS, INTRAMUSCULAR; MUSCLE FIBERS, SKELETAL; MYOSITIS; OXIDATIVE STRESS; RABBITS; STATISTICS, NONPARAMETRIC; TRANSFECTION; TRANSPLANTATION, AUTOLOGOUS;

EID: 84555187475     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.22248     Document Type: Article

References (38)

1. Partridge TA, Morgan JE, Coulton GR, Hoffman EP, Kunkel LM. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
2. Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006;15:659-663.
3. Perez-Ilzarbe M, Agbulut O, Pelacho B, Ciorba C, San Jose-Eneriz E, Desnos Me AA, et al. Characterization of the paracrine effects of human skeletal myoblasts transplanted in infarcted myocardium. Eur J Heart Fail 2008;10:1065-1072.
4. Zhang N, Li J, Luo R, Jiang J, Wang JA. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes 2008;116:104-111.
5. Kang SB, Lee HN, Lee JY, Park JS, Lee HS, Lee JY. Sphincter contractility after muscle-derived stem cells autograft into the cryoinjured anal sphincters of rats. Dis Colon Rectum 2008;51:1367-1373.
6. Lorenzi B, Pessina F, Lorenzoni P, Urbani S, Vernillo R, Sgaragli G, et al. Treatment of experimental injury of anal sphincters with primary surgical repair and injection of bone marrow-derived mesenchymal stem cells. Dis Colon Rectum 2008;51:411-420.
7. Carr LK, Steele D, Steele S, Wagner D, Pruchnic R, Jankowski R, et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008;19:881-883.
8. Mitterberger M, Pinggera GM, Marksteiner R, Margreiter E, Fussenegger M, Frauscher F, et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol 2008;53:169-175.
9. García-Olmo D, García-Arranz M, Herreros D, Pascual I, Peiro C, Rodríguez-Montes JA. A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005;48:1416-1423.
10. Boubaker el Andalousi R, Daussin PA, Micallef JP, Roux C, Nougues J, Chammas M, et al. Changes in mass and performance in rabbit muscles after muscle damage with or without transplantation of primary satellite cells. Cell Transplant 2002;11:169-180.
11. Beier JP, Stern-Straeter J, Foerster VT, Kneser U, Stark GB, Bach AD. Tissue engineering of injectable muscle: three-dimensional myoblastfibrin injection in the syngeneic rat animal model. Plast Reconstr Surg 2006;118:1113-1121.
12. De Coppi P, Bellini S, Conconi MT, Sabatti M, Simonato E, Gamba PG, et al. Myoblast-acellular skeletal muscle matrix constructs guarantee a long-term repair of experimental full-thickness abdominal wall defects. Tissue Eng 2006;12:1929-1936.
13. Dib N, Dinsmore J, Lababidi Z, White B, Moravec S, Campbell A, et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheterbased delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). J Am Coll Cardiol Cardiovasc Interv 2009;2:9-16.
14. Fan Y, Maley M, Beilharz M, Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996;19:853-860.
15. Huard J, Yokoyama T, Pruchnic R, Qu Z, Li Y, Lee JY, et al. Musclederived cell-mediated ex vivo gene therapy for urological dysfunction. Gene Ther 2002;9:1617-1626.
16. Suzuki K, Murtuza B, Beauchamp JR, Smolenski RT, Varela-Carver A, Fukushima S, et al. Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB J 2004;18:1153-1155.
17. Guo C, Haider HK, Shim WS, Tan RS, Ye L, Jiang S, Law PK, et al. Myoblast-based cardiac repair: xenomyoblast versus allomyoblast transplantation. J Thorac Cardiovasc Surg 2007;134:1332-1339.
18. Hodgetts SI, Beilharz MW, Scalzo AA, Grounds MD. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant 2000;9:489-502.
19. Holzer N, Hogendoorn S, Zurcher L, Garavaglia G, Yang S, Konig S, et al. Autologous transplantation of porcine myogenic precursor cells in skeletal muscle. Neuromuscul Disord 2005;15:237-244.
20. Asakura A, Hirai H, Kablar B, Morita S, Ishibashi J, Piras BA, et al. Increased survival of muscle stem cells lacking the MyoD gene after transplantation into regenerating skeletal muscle. Proc Natl Acad Sci USA 2007;104:16552-16557.
21. Xu X, Yang Z, Liu Q, Wang Y. In vivo fluorescence imaging of muscle cell regeneration by transplanted EGFP-labeled myoblasts. Mol Ther 2010;18:835-842.
22. Burdzińska A, Bartoszuk-Bruzzone U, Godlewski MM, Orzechowski A. Sodium ascorbate and basic fibroblast growth factor protect muscle- derived cells from H2O2-induced oxidative stress. Comp Med 2006;56:493-501.
23. Sampaolesi M, Blot S, D'Antona G, Granger N, Tonlorenzi R, Innocenzi A, et al. Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 2006;444:574-579.
24. El Fahime E, Bouchentouf M, Benabdallah BF, Skuk D, Lafreniere JF, Chang YT, et al. Tubulyzine, a novel tri-substituted triazine, prevents the early cell death of transplanted myogenic cells and improves transplantation success. Biochem Cell Biol 2003;81:81-90.
25. Lee JY, Cannon TW, Pruchnic R, Fraser MO, Huard J, Chancellor MB, et al. The effects of periurethral muscle-derived stem cell injection on leak point pressure in a rat model of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2003;14:31-37.
26. Jackson KA, Snyder DS, Goodell MA. Skeletal muscle fiber-specific green autofluorescence: potential for stem cell engraftment artifacts. Stem Cells 2004;22:180-187.
27. Blaveri K, Heslop L, Yu DS, Rosenblatt JD, Gross JG, Partridge TA, et al. Patterns of repair of dystrophic mouse muscle: studies on isolated fibers. Dev Dyn 1999;216:244-256.
28. Collins CA, Partridge TA. Self-renewal of the adult skeletal muscle satellite cell. Cell Cycle 2005;4:1338-1341.
29. Reinecke H, Poppa V, Murry CE. Skeletal muscle stem cells do not transdifferentiate into cardiomyocytes after cardiac grafting. J Mol Cell Cardiol 2002;34:241-249.
30. Gavira JJ, Perez-Ilzarbe M, Abizanda G, García-Rodríguez A, Orbe J, Pa ́ramo JA, et al. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Cardiovasc Res 2006;71:744-753.
31. Leobon B, Garcin I, Menasche P, Vilquin JT, Audinat E, Charpak S. Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host. Proc Natl Acad Sci USA 2003;100:7808-7811.
32. César M, Roussanne-Domergue S, Coulet B, Gay S, Micallef JP, Chammas M, et al. Transplantation of adult myoblasts or adipose tissue precursor cells by high-density injection failed to improve reinnervated skeletal muscles. Muscle Nerve 2008;37:219-230.
33. Bouchentouf M, Benabdallah BF, Bigey P, Yau TM, Scherman D, Tremblay JP. Vascular endothelial growth factor reduced hypoxiainduced death of human myoblasts and improved their engraftment in mouse muscles. Gene Ther 2008;15:404-414.
34. Bouchentouf M, Benabdallah BF, Rousseau J, Schwartz LM, Tremblay JP. Induction of Anoikis following myoblast transplantation into SCID mouse muscles requires the Bit1 and FADD pathways. Am J Transplant 2007;7:1491-1505.
35. Niagara MI, Haider HK, Jiang S, Ashraf M. Pharmacologically preconditioned skeletal myoblasts are resistant to oxidative stress and promote angiomyogenesis via release of paracrine factors in the infarcted heart. Circ Res 2007;100:545-555.
36. Burdzińska A, Bartoszuk U, Orzechowski A. Preincubation with bFGF but not sodium ascorbate improves efficiency of autologous transplantation of muscle-derived cells into urethral wall. Urology 2009; 73:736-742.
37. Qu-Petersen Z, Deasy B, Jankowski R, Ikezawa M, Cummins J, Pruchnic R, et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 2002;157:851-864.
38. Urish KL, Vella JB, Okada M, Deasy BM, Tobita K, Keller BB, et al. Antioxidant levels represent a major determinant in the regenerative capacity of muscle stem cells. Mol Biol Cell 2009;20:509-520.